Abstract
Abstract
Background
Uterine artery embolization is proven to be an effective treatment for symptomatic uterine fibroids. Yet, its role in the management of dysfunctional uterine bleeding is still debatable. Patients with dysfunctional uterine bleeding have abnormal bleeding from the uterine vascular bed with variable underlying mechanisms. Uterine artery embolization will reduce/prevent bleeding by occlusion of the vascular bed, with subsequent cutoff of the effect of hormones on the endometrium. The aim of this work is to demonstrate the safety, efficacy and possible short-term complications of uterine artery embolization in the treatment of dysfunctional uterine bleeding (DUB) as a first-line treatment modality rather than the current treatment options (hormonal and surgical treatment).
Methods
Thirty patients included in the study were clinically and laboratory diagnosed based on FIGO classification system (PALM-COEIN) as DUB, and the diagnosis was confirmed by MRI imaging. All patients were subjected to transcatheter uterine artery embolization with subsequent clinical and radiological follow-up to assess the treatment outcome.
Results
Uterine artery embolization was able to control bleeding in patients diagnosed as DUB, with subsequent complete cessation of medical treatment; no surgical interference was needed with much less morbidity. We had 93.3% improvement in the frequency, volume of bleeding and 100% improvement of the presenting anemia. No significant change in uterine volume or in endometrial thickness has been noted.
Conclusions
Uterine artery embolization is safe, effective procedure to control dysfunctional uterine bleeding with the preservation of the uterus especially in critical age groups.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Sangeetha R (2022) Period pain in adolescents and therapeutics in homeopathy. J Med Pharm Innov 9(45).
2. Hurskainen R, Teperi J, Rissanen P, Aalto A-M, Grenman S, Kivelä A et al (2004) Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291(12):1456–1463
3. Fraser IS, Critchley HO, Munro MG (2007) Abnormal uterine bleeding: getting our terminology straight. Curr Opin Obstet Gynecol 19(6):591–595
4. Fraser IS, Critchley HO, Broder M, Munro MG (eds) (2011) The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Seminars in reproductive medicine. Thieme Medical Publishers.
5. Davis E, Sparzak PB (2018) Abnormal uterine bleeding